We do not diagnose disease or recommend a dietary supplement for the treatment of disease. You should share this information with your physician who can determine what nutrition, disease and injury treatment regimen is best for you. You can search this site or the web for topics of interest that I may have written (use Dr Simone and topic).
“We provide truthful information without emotion or influence from the medical establishment, pharmaceutical industry, national organizations, special interest groups or government agencies.” Charles B Simone, M.MS., M.D.
HOSPITALS, INSURERS, PHARMACY BENEFIT MANAGERS, GOVERNMENT GET 50% OF DRUG SPENDING
Lawrenceville, NJ (Dr Charles Simone) – According to the Berkeley Research Group, 50% of the money spent on brand name medicines in 2018 went to hospitals, health insurers, pharmacy benefit managers, the government, and others – increasing from $24.7 billion to $48.6 billion between 2013 and 2018. This increase is mainly due to the 340B Program started in 1992 by Congress for indigent patients that has grown 9 times larger in 2018 than in 2013. The 340B program compels Big Pharma to provide large discounts on medicines to designated Disproportionate Share Hospitals and clinics as a condition of their drugs being covered by Medicaid. However, some designated hospitals and clinics take advantage of the program.
80% of 340B dollars go to Disproportionate Share Hospitals, even though Disproportionate Share Hospitals are 9% of 340B entities
45% of all Medicare acute care hospitals participate in 340B
64% of hospitals have charity care rates below 2.2% of the national average for all hospitals.
© Charles B. Simone, M.MS., M.D.
